Trevor J B Dummer1, Philip Awadalla2, Catherine Boileau2, Camille Craig2, Isabel Fortier2, Vivek Goel2, Jason M T Hicks2, Sébastien Jacquemont2, Bartha Maria Knoppers2, Nhu Le2, Treena McDonald2, John McLaughlin2, Anne-Marie Mes-Masson2, Anne-Monique Nuyt2, Lyle J Palmer2, Louise Parker2, Mark Purdue2, Paula J Robson2, John J Spinelli2, David Thompson2, Jennifer Vena2, Ma'n Zawati2. 1. School of Population and Public Health (Dummer), University of British Columbia, Vancouver, BC; Ontario Institute for Cancer Research (Awadalla); CARTaGENE (Boileau), Montréal, Que.; Research Institute of the McGill University Health Centre (Craig, Fortier); Research and Innovation, University of Toronto (Goel); Ontario Agency for Health Protection and Promotion (Goel); Atlantic PATH, Dalhousie University (Hicks), Halifax, NS; Centre hospitalier universitaire Sainte-Justine (Jacquemont); Centre of Genomics and Policy, McGill University (Knoppers, Zawati), Montréal, Que.; BC Cancer Research Centre (Le, McDonald), Vancouver, BC; Public Health Ontario (McLaughlin), Toronto, Ont.; Institut du cancer de Montréal, Université de Montréal (Mes-Masson); Pediatrics, CHU Sainte-Justine Research Center (Nuyt), Montréal, Que.; School of Public Health, University of Adelaide (Palmer), Adelaide, Australia; Department of Medicine, Dalhousie University (Parker); Division of Cancer Epidemiology and Genetics, National Cancer Institute (Purdue), Bethesda, Md.; CancerControl Alberta, Alberta Health Services (Robson, Vena), Edmonton, Alta.; Population Oncology, BC Cancer (Spinelli), Vancouver, BC; Atlantic PATH, Dalhousie University (Thompson), Halifax, NS trevor.dummer@ubc.ca. 2. School of Population and Public Health (Dummer), University of British Columbia, Vancouver, BC; Ontario Institute for Cancer Research (Awadalla); CARTaGENE (Boileau), Montréal, Que.; Research Institute of the McGill University Health Centre (Craig, Fortier); Research and Innovation, University of Toronto (Goel); Ontario Agency for Health Protection and Promotion (Goel); Atlantic PATH, Dalhousie University (Hicks), Halifax, NS; Centre hospitalier universitaire Sainte-Justine (Jacquemont); Centre of Genomics and Policy, McGill University (Knoppers, Zawati), Montréal, Que.; BC Cancer Research Centre (Le, McDonald), Vancouver, BC; Public Health Ontario (McLaughlin), Toronto, Ont.; Institut du cancer de Montréal, Université de Montréal (Mes-Masson); Pediatrics, CHU Sainte-Justine Research Center (Nuyt), Montréal, Que.; School of Public Health, University of Adelaide (Palmer), Adelaide, Australia; Department of Medicine, Dalhousie University (Parker); Division of Cancer Epidemiology and Genetics, National Cancer Institute (Purdue), Bethesda, Md.; CancerControl Alberta, Alberta Health Services (Robson, Vena), Edmonton, Alta.; Population Oncology, BC Cancer (Spinelli), Vancouver, BC; Atlantic PATH, Dalhousie University (Thompson), Halifax, NS.
Abstract
BACKGROUND: Understanding the complex interaction of risk factors that increase the likelihood of developing common diseases is challenging. The Canadian Partnership for Tomorrow Project (CPTP) is a prospective cohort study created as a population-health research platform for assessing the effect of genetics, behaviour, family health history and environment (among other factors) on chronic diseases. METHODS: Volunteer participants were recruited from the general Canadian population for a confederation of 5 regional cohorts. Participants were enrolled in the study and core information obtained using 2 approaches: attendance at a study assessment centre for all study measures (questionnaire, venous blood sample and physical measurements) or completion of the core questionnaire (online or paper), with later collection of other study measures where possible. Physical measurements included height, weight, percentage body fat and blood pressure. Participants consented to passive follow-up through linkage with administrative health databases and active follow-up through recontact. All participant data across the 5 regional cohorts were harmonized. RESULTS: A total of 307 017 participants aged 30-74 from 8 provinces were recruited. More than half provided a venous blood sample and/or other biological sample, and 33% completed physical measurements. A total of 709 harmonized variables were created; almost 25% are available for all participants and 60% for at least 220 000 participants. INTERPRETATION: Primary recruitment for the CPTP is complete, and data and biosamples are available to Canadian and international researchers through a data-access process. The CPTP will support research into how modifiable risk factors, genetics and the environment interact to affect the development of cancer and other chronic diseases, ultimately contributing evidence to reduce the global burden of chronic disease.
BACKGROUND: Understanding the complex interaction of risk factors that increase the likelihood of developing common diseases is challenging. The Canadian Partnership for Tomorrow Project (CPTP) is a prospective cohort study created as a population-health research platform for assessing the effect of genetics, behaviour, family health history and environment (among other factors) on chronic diseases. METHODS: Volunteer participants were recruited from the general Canadian population for a confederation of 5 regional cohorts. Participants were enrolled in the study and core information obtained using 2 approaches: attendance at a study assessment centre for all study measures (questionnaire, venous blood sample and physical measurements) or completion of the core questionnaire (online or paper), with later collection of other study measures where possible. Physical measurements included height, weight, percentage body fat and blood pressure. Participants consented to passive follow-up through linkage with administrative health databases and active follow-up through recontact. All participant data across the 5 regional cohorts were harmonized. RESULTS: A total of 307 017 participants aged 30-74 from 8 provinces were recruited. More than half provided a venous blood sample and/or other biological sample, and 33% completed physical measurements. A total of 709 harmonized variables were created; almost 25% are available for all participants and 60% for at least 220 000 participants. INTERPRETATION: Primary recruitment for the CPTP is complete, and data and biosamples are available to Canadian and international researchers through a data-access process. The CPTP will support research into how modifiable risk factors, genetics and the environment interact to affect the development of cancer and other chronic diseases, ultimately contributing evidence to reduce the global burden of chronic disease.
Authors: Christian Herder; Jens Baumert; Astrid Zierer; Michael Roden; Christa Meisinger; Mahir Karakas; Lloyd Chambless; Wolfgang Rathmann; Annette Peters; Wolfgang Koenig; Barbara Thorand Journal: PLoS One Date: 2011-06-06 Impact factor: 3.240
Authors: Mark S Pearce; James C McConnell; Catherine Potter; Laura M Barrett; Louise Parker; John C Mathers; Caroline L Relton Journal: Int J Epidemiol Date: 2012-02 Impact factor: 7.196
Authors: Francesca L Crowe; Naomi E Allen; Paul N Appleby; Kim Overvad; Inge V Aardestrup; Nina F Johnsen; Anne Tjønneland; Jakob Linseisen; Rudolf Kaaks; Heiner Boeing; Janine Kröger; Antonia Trichopoulou; Assimina Zavitsanou; Dimitrios Trichopoulos; Carlotta Sacerdote; Domenico Palli; Rosario Tumino; Claudia Agnoli; Lambertus A Kiemeney; H Bas Bueno-de-Mesquita; María-Dolores Chirlaque; Eva Ardanaz; Nerea Larrañaga; José R Quirós; Maria-José Sánchez; Carlos A González; Pär Stattin; Göran Hallmans; Sheila Bingham; Kay-Tee Khaw; Sabina Rinaldi; Nadia Slimani; Mazda Jenab; Elio Riboli; Timothy J Key Journal: Am J Clin Nutr Date: 2008-11 Impact factor: 7.045
Authors: Melanie R Keats; Yunsong Cui; Vanessa DeClercq; Scott A Grandy; Ellen Sweeney; Trevor J B Dummer Journal: Support Care Cancer Date: 2020-05-22 Impact factor: 3.603
Authors: Ellen Sweeney; Zhijie Michael Yu; Trevor J B Dummer; Yunsong Cui; Vanessa DeClercq; Cynthia Forbes; Scott A Grandy; Melanie Keats; Louise Parker; Anil Adisesh Journal: Int Arch Occup Environ Health Date: 2019-07-26 Impact factor: 3.015
Authors: Lee Ingle; Samantha Ruilova; Yunsung Cui; Vanessa DeClercq; Ellen Sweeney; Zhijie Michael Yu; Cynthia C Forbes Journal: Cancer Causes Control Date: 2022-06-14 Impact factor: 2.532
Authors: Melanie R Keats; Yunsong Cui; Vanessa DeClercq; Scott A Grandy; Ellen Sweeney; Trevor J B Dummer Journal: Int J Environ Res Public Health Date: 2020-11-20 Impact factor: 3.390
Authors: Esther S Shoemaker; Marissa L Becker; Clare E Liddy; Leigh M McClarty; Shabnam Asghari; Jillian Hurd; Sean B Rourke; Souradet Y Shaw; Christine Bibeau; Ron Rosenes; Philip Lundrigan; Lois Crowe; Laurie Ireland; Carla Loeppky; Claire E Kendall Journal: Healthc Policy Date: 2019-08